Ironwood Pharma (IRWD) Tops Q3 EPS by 2c

Ironwood Pharma (NASDAQ: IRWD) reported Q3 EPS of $0.33, $0.02 better than the analyst estimate of $0.31. Revenue for the quarter came in at $103.8 million versus the consensus estimate of $105.4 million.

GUIDANCE:

Ironwood Pharma sees FY2021 revenue of $390-410 million, versus the consensus of $408 million.

For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• SPS Commerce hires Morgan Stanley to explore sale amid activist push - Reuters
• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI